| Literature DB >> 20831538 |
E Piñana1, S H Lei, R Merino, M Melgosa, R De La Vega, E Gonzales-Obeso, E Ramírez, A Borobia, A Carcas.
Abstract
DRESS-syndrome (Drug Rash with Eosinophilia and Systemic Symptoms) is a severe drug-induced hypersensitivity syndrome characterized by diffuse maculopapular rash, lymphadenopathy, multivisceral involvement, eosinophilia and atypical lymphocytes with a mortality rate of 10-40% (Seminars in Cutaneous Medicine and Surgery, 1, 250). It is described in adults treated with aromatic antiepileptics and less frequently with sulphonamides, and non-steroidal anti-inflammatory drugs (Clinics in Dermatology, 23, 171; Pediatrics, 108, 485). We report on an 11-year-old Caucasian boy hospitalized with a skin eruption, lymphadenopathy, acute hepatitis, renal tubular involvement, haematological abnormalities and human-herpevirus-6 reactivation, treated with sulfasalazine and naproxen for juvenile idiopathic arthritis (JIA). This is the first report in children with rheumatic disease and highlights the possibility of sulfasalazine and naproxen-induced-DRESS-syndrome in children with JIA.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20831538 DOI: 10.1111/j.1365-2710.2009.01081.x
Source DB: PubMed Journal: J Clin Pharm Ther ISSN: 0269-4727 Impact factor: 2.512